“Role of 18F-FDG PET CT in Assessment of Recurrence and Metastases in Female Breast Carcinoma Patients in Relation to Immunohistochemical Markers: Emphasis on HER2 Status, SUVmax Correlation, and Alignment With 2025 2026 EANM SNMMI Guidelines”. 2026. Bangladesh Journal of Nuclear Medicine 29 (1): 28-35. https://doi.org/10.3329/bjnm.v29i1.89278.